Progyny, Inc. (NASDAQ:PGNY) Shares Sold by Yousif Capital Management LLC

Yousif Capital Management LLC lowered its holdings in Progyny, Inc. (NASDAQ:PGNY) by 2.8% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 28,021 shares of the company’s stock after selling 794 shares during the quarter. Yousif Capital Management LLC’s holdings in Progyny were worth $626,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently made changes to their positions in the business. Signaturefd LLC grew its position in Progyny by 1,355.0% during the fourth quarter. Signaturefd LLC now owns 1,455 shares of the company’s stock valued at $25,000 after buying an additional 1,355 shares during the period. Natixis purchased a new position in Progyny during the fourth quarter valued at $69,000. SBI Securities Co. Ltd. purchased a new position in Progyny during the fourth quarter valued at $74,000. Amundi purchased a new position in Progyny during the fourth quarter valued at $102,000. Finally, Covestor Ltd lifted its holdings in Progyny by 69.4% during the fourth quarter. Covestor Ltd now owns 6,868 shares of the company’s stock valued at $118,000 after purchasing an additional 2,814 shares in the last quarter. Institutional investors and hedge funds own 94.93% of the company’s stock.

Analyst Upgrades and Downgrades

Several equities analysts have recently weighed in on PGNY shares. BTIG Research raised shares of Progyny from a “neutral” rating to a “buy” rating and set a $28.00 price target on the stock in a research note on Monday, March 31st. Canaccord Genuity Group decreased their price target on shares of Progyny from $23.00 to $21.00 and set a “hold” rating on the stock in a research note on Monday, May 12th. Seven investment analysts have rated the stock with a hold rating and five have given a buy rating to the company. According to MarketBeat, the stock presently has a consensus rating of “Hold” and an average price target of $23.45.

Insider Buying and Selling

In related news, Director Cheryl Scott sold 2,675 shares of the firm’s stock in a transaction on Wednesday, June 11th. The stock was sold at an average price of $22.07, for a total value of $59,037.25. Following the transaction, the director now owns 14,112 shares in the company, valued at approximately $311,451.84. This trade represents a 15.93% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. 9.40% of the stock is owned by company insiders.

Progyny Stock Performance

PGNY stock opened at $20.98 on Friday. The stock has a market cap of $1.80 billion, a P/E ratio of 36.81, a P/E/G ratio of 2.28 and a beta of 1.32. The firm has a 50 day simple moving average of $21.87 and a 200 day simple moving average of $20.78. Progyny, Inc. has a 52 week low of $13.39 and a 52 week high of $30.42.

Progyny (NASDAQ:PGNY) last announced its earnings results on Thursday, May 8th. The company reported $0.17 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.45 by ($0.28). The company had revenue of $324.04 million for the quarter, compared to the consensus estimate of $307.86 million. Progyny had a return on equity of 10.90% and a net margin of 4.33%. The company’s revenue was up 16.5% compared to the same quarter last year. During the same period last year, the firm posted $0.17 EPS. Sell-side analysts predict that Progyny, Inc. will post 0.6 EPS for the current year.

Progyny Profile

Progyny, Inc, a benefits management company, specializes in fertility and family building benefits solutions in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists.